Seller record · Telehealth service

Ambiante Health & Wellness

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The program pages refer only to partner compounding pharmacies in the United States, and the terms, privacy policy and HIPAA notice name none. 2 more criteria also fail; see the table below.

At a glance

Ambiante Health & WellnessTelehealth service

5/8criteria passed
Price
Compounded semaglutide injection or GLP-1 microdose from $179 a month; tirzepatide injection from $199 a month
Sells
compounded semaglutide injection, compounded tirzepatide injection, and 6 more
FDA letters
None on file
Visit Ambiante Health & WellnessSee all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A Massachusetts telehealth practice for women selling compounded semaglutide, tirzepatide, oral GLP-1 and microdose programs at a flat monthly rate, plus tesamorelin, sermorelin, NAD+ and PT-141, reviewed by independent licensed providers after an online assessment.

Operating entity Ambiante Health & Wellness LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSAmbiante Health & Wellness' semaglutide product page; Ambiante Health & Wellness' website
S2Prescription gatingPASSAmbiante Health & Wellness' peptides page; Ambiante Health & Wellness' semaglutide product page; Ambiante Health & Wellness' about page
S3Pharmacy identificationFAILAmbiante Health & Wellness' semaglutide product page; Ambiante Health & Wellness' terms; Ambiante Health & Wellness' HIPAA page
S4Compounding disclosureFAILAmbiante Health & Wellness' semaglutide product page; Ambiante Health & Wellness' website; Ambiante Health & Wellness' peptides page
S5Analytical documentationFAILAmbiante Health & Wellness' semaglutide product page; Ambiante Health & Wellness' peptides page; Ambiante Health & Wellness' terms; Ambiante Health & Wellness' privacy page
S6Business addressPASSAmbiante Health & Wellness' privacy page; Ambiante Health & Wellness' contact page
S7Price disclosurePASSAmbiante Health & Wellness' peptides page; Ambiante Health & Wellness' semaglutide product page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEach consultation is reviewed and authorized by an independent, licensed provider, and the footer says all consultations, clinical evaluations and prescription decisions are made solely by independent licensed practitioners.Source: Ambiante Health & Wellness' semaglutide product page; Ambiante Health & Wellness' website.
S2PASSThe steps list a short assessment first and a licensed provider's review second, every program is said to begin with an online consultation, and the about page says nothing is charged if the patient is not approved.Source: Ambiante Health & Wellness' peptides page; Ambiante Health & Wellness' semaglutide product page; Ambiante Health & Wellness' about page.
S3FAILNo filling pharmacy is named. The program pages refer only to partner compounding pharmacies in the United States, and the terms, privacy policy and HIPAA notice name none.Source: Ambiante Health & Wellness' semaglutide product page; Ambiante Health & Wellness' terms; Ambiante Health & Wellness' HIPAA page.
S4FAILEvery program includes compounded medication prepared by partner compounding pharmacies, yet the disclaimer in the footer of every page states that medications, where prescribed, are FDA-approved products dispensed by licensed pharmacies. Only the peptides page adds that compounded medications are not FDA-approved.Source: Ambiante Health & Wellness' semaglutide product page; Ambiante Health & Wellness' website; Ambiante Health & Wellness' peptides page.
S5FAILNo certificate of analysis or lot document is published on the program pages, the peptides page, the terms or the privacy policy.Source: Ambiante Health & Wellness' semaglutide product page; Ambiante Health & Wellness' peptides page; Ambiante Health & Wellness' terms; Ambiante Health & Wellness' privacy page.
S6PASSAmbiante Health & Wellness LLC at 189 Belmont Street, Brockton, MA 02301, printed twice in the privacy policy as its mailing address, with Brockton, Massachusetts on the contact page.Source: Ambiante Health & Wellness' privacy page; Ambiante Health & Wellness' contact page.
S7PASSSemaglutide injections and GLP-1 microdosing start at $179 a month, the oral GLP-1 and tirzepatide injections at $199 a month, tesamorelin at $299, sermorelin at $199, NAD+ at $179 and PT-141 at $249 a month, with no consultation charge or dose-change surcharge.Source: Ambiante Health & Wellness' peptides page; Ambiante Health & Wellness' semaglutide product page.
S8PASSNo FDA warning letter names Ambiante Health & Wellness or Ambiante Health & Wellness LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, compounded tirzepatide injection, GLP-1 microdose, GLP-1 oral, tesamorelin, sermorelin, NAD+, PT-141.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells PT-141Who sells tesamorelin

Visit Ambiante Health & Wellness

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.